Citations (68)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Nafeesah Isa, Durrah Mudhafar, Chengsheng Ju, Kenneth K. C. Man, Wallis C. Y. Lau, Lok Yin Cheng & Li Wei. (2022) Effects of Phosphodiesterase-5 Inhibitors in Patients with Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis. COPD: Journal of Chronic Obstructive Pulmonary Disease 19:1, pages 300-308.
Read now
Read now
Isabel Blanco, Olga Tura-Ceide, Victor Ivo Peinado & Joan Albert Barberà. (2020) Updated Perspectives on Pulmonary Hypertension in COPD. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 1315-1324.
Read now
Read now
Zhouxin Ren, Jiansheng Li, Junling Shen, Haibin Yu, Xiaofeng Mei, Peng Zhao, Zhenya Xiao & Wanliu Wu. (2020) Therapeutic sildenafil inhibits pulmonary damage induced by cigarette smoke exposure and bacterial inhalation in rats. Pharmaceutical Biology 58:1, pages 116-123.
Read now
Read now
Sarah K. Medrek, Amir Sharafkhaneh, Andrew M. Spiegelman, Arnav Kak & Lavannya M. Pandit. (2017) Admission for COPD Exacerbation Is Associated with the Clinical Diagnosis of Pulmonary Hypertension: Results from a Retrospective Longitudinal Study of a Veteran Population. COPD: Journal of Chronic Obstructive Pulmonary Disease 14:5, pages 484-489.
Read now
Read now
Articles from other publishers (64)
Michael Halank, Katarina E. Zeder, Natascha SommerSilvia Ulrich, Matthias Held, Thomas Köhler, Vasile Foris, Melanie Heberling, Claus Neurohr, Julia Ronczka, Stephan Holt, Dirk Skowasch, Nikolaus Kneidinger & Jürgen Behr. (2023) Pulmonale Hypertonie assoziiert mit Lungenerkrankungen. Pneumologie 77:11, pages 916-925.
Crossref
Crossref
Han Liu, Pengbei Fan, Fanli Jin, Hui Ren, Feng Xu & Jiansheng Li. (2023) Targeting biophysical microenvironment for improved treatment of chronic obstructive pulmonary disease. Trends in Molecular Medicine 29:11, pages 926-938.
Crossref
Crossref
Lucilla Piccari, Ricardo Aguilar-Colindres & Diego A. Rodríguez-Chiaradía. (2023) Pulmonary hypertension in interstitial lung disease and in chronic obstructive pulmonary disease: different entities?. Current Opinion in Pulmonary Medicine 29:5, pages 370-379.
Crossref
Crossref
Mahdieh Golzari-Sorkheh, Imindu Liyanage, Mark A. Reed & Donald F. Weaver. (2023) Alzheimer’s Disease and COVID-19 Pathogenic Overlap: Implications for Drug Repurposing. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, pages 1-12.
Crossref
Crossref
Janae Gonzales & Dustin R. Fraidenburg. (2023) Pharmacology and Emerging Therapies for Group 3 Pulmonary Hypertension Due to Chronic Lung Disease. Pharmaceuticals 16:3, pages 418.
Crossref
Crossref
Marc Humbert, Gabor Kovacs, Marius M. Hoeper, Roberto Badagliacca, Rolf M.F. Berger, Margarita Brida, Jørn Carlsen, Andrew J.S. Coats, Pilar Escribano-Subias, Pisana Ferrari, Diogenes S. Ferreira, Hossein Ardeschir Ghofrani, George Giannakoulas, David G. Kiely, Eckhard Mayer, Gergely Meszaros, Blin Nagavci, Karen M. Olsson, Joanna Pepke-Zaba, Jennifer K. Quint, Göran Rådegran, Gerald Simonneau, Olivier Sitbon, Thomy Tonia, Mark Toshner, Jean-Luc Vachiery, Anton Vonk Noordegraaf, Marion Delcroix & Stephan Rosenkranz. (2023) 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. European Respiratory Journal 61:1, pages 2200879.
Crossref
Crossref
J. Alberto Neder, Miranda Kirby, Giles Santyr, Marina Pourafkari, Reginald Smyth, Devin B. Phillips, Sophie Crinion, Juan Pablo de-Torres & Denis E. O’Donnell. (2022) V̇/Q̇ Mismatch. CHEST 162:5, pages 1030-1047.
Crossref
Crossref
Marc Humbert, Gabor Kovacs, Marius M Hoeper, Roberto Badagliacca, Rolf M F Berger, Margarita Brida, Jørn Carlsen, Andrew J S Coats, Pilar Escribano-Subias, Pisana Ferrari, Diogenes S Ferreira, Hossein Ardeschir Ghofrani, George Giannakoulas, David G Kiely, Eckhard Mayer, Gergely Meszaros, Blin Nagavci, Karen M Olsson, Joanna Pepke-Zaba, Jennifer K Quint, Göran Rådegran, Gerald Simonneau, Olivier Sitbon, Thomy Tonia, Mark Toshner, Jean Luc Vachiery, Anton Vonk Noordegraaf, Marion Delcroix, Stephan Rosenkranz, Markus Schwerzmann, Anh Tuan Dinh-Xuan, Andy Bush, Magdy Abdelhamid, Victor Aboyans, Eloisa Arbustini, Riccardo Asteggiano, Joan Albert Barberà, Maurice Beghetti, Jelena Čelutkienė, Maja Cikes, Robin Condliffe, Frances de Man, Volkmar Falk, Laurent Fauchier, Sean Gaine, Nazzareno Galié, Wendy Gin-Sing, John Granton, Ekkehard Grünig, Paul M Hassoun, Merel Hellemons, Tiny Jaarsma, Barbro Kjellström, Frederikus A Klok, Aleksandra Konradi, Konstantinos C Koskinas, Dipak Kotecha, Irene Lang, Basil S Lewis, Ales Linhart, Gregory Y H Lip, Maja Lisa Løchen, Alexander G Mathioudakis, Richard Mindham, Shahin Moledina, Robert Naeije, Jens Cosedis Nielsen, Horst Olschewski, Isabelle Opitz, Steffen E Petersen, Eva Prescott, Amina Rakisheva, Abilio Reis, Arsen D Ristić, Nicolas Roche, Rita Rodrigues, Christine Selton-Suty, Rogerio Souza, Andrew J Swift, Rhian M Touyz, Silvia Ulrich, Martin R Wilkins & Stephen John Wort. (2022) 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. European Heart Journal 43:38, pages 3618-3731.
Crossref
Crossref
Kareem Ahmad, Vikramjit Khangoora & Steven D. Nathan. (2022) Lung Disease–Related Pulmonary Hypertension. Cardiology Clinics 40:1, pages 77-88.
Crossref
Crossref
Keski Hakan & Demirtunç Refik. (2021) Effects of Sildenafil on spirometric pulmonary function parameters, pulmonary artery systolic pressure and BNP levels in patients with chronic obstructive pulmonary disease and erectile dysfunction. IP Indian Journal of Immunology and Respiratory Medicine 6:4, pages 226-233.
Crossref
Crossref
Carmine Dario Vizza, Marius M. Hoeper, Doerte Huscher, David Pittrow, Nicola Benjamin, Karen M. Olsson, H. Ardeschir Ghofrani, Matthias Held, Hans Klose, Tobias Lange, Stephan Rosenkranz, Daniel Dumitrescu, Roberto Badagliacca, Martin Claussen, Michael Halank, Anton Vonk-Noordegraaf, Dirk Skowasch, Ralf Ewert, J. Simon R. Gibbs, Marion Delcroix, Andris Skride, Gerry Coghlan, Silvia Ulrich, Christian Opitz, Harald Kaemmerer, Oliver Distler & Ekkehard Grünig. (2021) Pulmonary Hypertension in Patients With COPD. Chest 160:2, pages 678-689.
Crossref
Crossref
Kari R. Gillmeyer, Donald R. Miller, Mark E. Glickman, Shirley X. Qian, Elizabeth S. Klings, Bradley A. Maron, Joseph T. Hanlon, Seppo T. Rinne & Renda S. Wiener. (2021) Outcomes of pulmonary vasodilator use in Veterans with pulmonary hypertension associated with left heart disease and lung disease. Pulmonary Circulation 11:2, pages 1-12.
Crossref
Crossref
Devin B. Phillips, Andrew R. Brotto, Bryan A. Ross, Tracey L. Bryan, Eric Y.L. Wong, Victoria L. Meah, Desi P. Fuhr, Sean van Diepen & Michael K. Stickland. (2021) Inhaled nitric oxide improves ventilatory efficiency and exercise capacity in patients with mild COPD: A randomized‐control cross‐over trial. The Journal of Physiology 599:5, pages 1665-1683.
Crossref
Crossref
Marija Gredic, Isabel Blanco, Gabor Kovacs, Zsuzsanna Helyes, Péter Ferdinandy, Horst Olschewski, Joan Albert Barberà & Norbert Weissmann. (2020) Pulmonary hypertension in chronic obstructive pulmonary disease. British Journal of Pharmacology 178:1, pages 132-151.
Crossref
Crossref
Yingying Hao, Yingwei Zhu, Yimin Mao, Jingduan Xu, Xuegai He, Shenshen Huang, Min Wang & Jiayong Qiu. (2020) Efficacy and safety of Sildenafil treatment in pulmonary hypertension caused by chronic obstructive pulmonary disease: A meta-analysis. Life Sciences 257, pages 118001.
Crossref
Crossref
Yaniv Dotan, Jeffrey Stewart, Andrew Gangemi, He Wang, Amandeep Aneja, Baidarbhi Chakraborty, Chandra Dass, Huaqing Zhao, Nathaniel Marchetti, Gilbert D'Alonzo, Francis C Cordova, Gerard Criner & Albert James Mamary. (2020) Pulmonary vasculopathy in explanted lungs from patients with interstitial lung disease undergoing lung transplantation. BMJ Open Respiratory Research 7:1, pages e000532.
Crossref
Crossref
Etienne-Marie Jutant, Maria-Rosa Ghigna, David Montani & Marc Humbert. 2020. Cardiovascular Complications of Respiratory Disorders. Cardiovascular Complications of Respiratory Disorders
167
183
.
Kari R. GillmeyerSeppo T. RinneMark E. GlickmanKyung Min LeeQing ShaoShirley X. QianElizabeth S. KlingsBradley A. MaronJoseph T. HanlonDonald R. MillerRenda Soylemez Wiener. (2020) Factors Associated With Potentially Inappropriate Phosphodiesterase-5 Inhibitor Use for Pulmonary Hypertension in the United States, 2006 to 2015. Circulation: Cardiovascular Quality and Outcomes 13:5.
Crossref
Crossref
Jason Weatherald, David Montani & Olivier Sitbon. 2020. Cardiac Considerations in Chronic Lung Disease. Cardiac Considerations in Chronic Lung Disease
79
96
.
Zoe White, Nadia Milad, Arash Y. Tehrani, Jennifer Lamothe, James C. Hogg, Mitra Esfandiarei, Michael Seidman, Steven Booth, Tillie-Louise Hackett, Mathieu C. Morissette & Pascal Bernatchez. (2019) Sildenafil Prevents Marfan-Associated Emphysema and Early Pulmonary Artery Dilation in Mice. The American Journal of Pathology 189:8, pages 1536-1546.
Crossref
Crossref
Steven D. Nathan, Joan A. Barbera, Sean P. Gaine, Sergio Harari, Fernando J. Martinez, Horst Olschewski, Karen M. Olsson, Andrew J. Peacock, Joanna Pepke-Zaba, Steeve Provencher, Norbert Weissmann & Werner Seeger. (2019) Pulmonary hypertension in chronic lung disease and hypoxia. European Respiratory Journal 53:1, pages 1801914.
Crossref
Crossref
Yi Zhang, Peiyi Lin, Cheng Hong, Qian Jiang, Yue Xing, Xiaoyan Tang, Huilin Jiang, Shuhong Luo & Xiaohui Chen. (2018) Serum cytokine profiles in patients with chronic obstructive pulmonary disease associated pulmonary hypertension identified using protein array. Cytokine 111, pages 342-349.
Crossref
Crossref
Gabor Kovacs, Alvar Agusti, Joan Albert Barberà, Bartolome Celli, Gerard Criner, Marc Humbert, Don D. Sin, Norbert Voelkel & Horst Olschewski. (2018) Pulmonary Vascular Involvement in Chronic Obstructive Pulmonary Disease. Is There a Pulmonary Vascular Phenotype?. American Journal of Respiratory and Critical Care Medicine 198:8, pages 1000-1011.
Crossref
Crossref
Deborah Kim, Kyung Min Lee, Marc R. Freiman, W. Ryan Powell, Elizabeth S. Klings, Seppo T. Rinne, Donald R. Miller, Adam J. Rose & Renda Soylemez Wiener. (2018) Phosphodiesterase-5 Inhibitor Therapy for Pulmonary Hypertension in the United States. Actual versus Recommended Use. Annals of the American Thoracic Society 15:6, pages 693-701.
Crossref
Crossref
Mehrdad Behnia, Courtney M. Wheatley, Alberto Avolio & Bruce D. Johnson. (2018) Influence of dietary nitrate supplementation on lung function and exercise gas exchange in COPD patients. Nitric Oxide 76, pages 53-61.
Crossref
Crossref
Sukhdeep Bhogal, Debabrata Mukherjee, Subhash Banerjee, AKM Monwarul Islam, Ramesh Daggubati & Timir K. Paul. (2018) Current Trends and Future Perspectives in the Treatment of Pulmonary Hypertension: WHO Group II-V. Current Problems in Cardiology 43:5, pages 217-231.
Crossref
Crossref
Nader Chebib, Jean‐François Mornex, Julie Traclet, François Philit, Chahera Khouatra, Sabrina Zeghmar, Ségolène Turquier & Vincent Cottin. (2018) Pulmonary hypertension in chronic lung diseases: comparison to other pulmonary hypertension groups. Pulmonary Circulation 8:2, pages 1-10.
Crossref
Crossref
Patrizio Vitulo, Anna Stanziola, Marco Confalonieri, Daniela Libertucci, Tiberio Oggionni, Paola Rottoli, Giuseppe Paciocco, Fabio Tuzzolino, Lavinia Martino, Marta Beretta, Adriana Callari, Andrea Amaducci, Roberto Badagliacca, Roberto Poscia, Federica Meloni, Rosa Metella Refini, Pietro Geri, Sergio Baldi, Stefano Ghio, Michele D’Alto, Paola Argiento, Matteo Sofia, Mara Guardamagna, Beatrice Pezzuto & Carmine Dario Vizza. (2017) Sildenafil in severe pulmonary hypertension associated with chronic obstructive pulmonary disease: A randomized controlled multicenter clinical trial. The Journal of Heart and Lung Transplantation 36:2, pages 166-174.
Crossref
Crossref
Samuel C Okpechi, Mohamed A Ghonim & Matthew R Lammi. (2017) Advances in Chronic Obstructive Pulmonary Disease Therapy: A Vascular-Targeted Approach. Clinical Medicine Insights: Therapeutics 9, pages 1179559X1771912.
Crossref
Crossref
Kurt W. Prins, Sue Duval, Jeremy Markowitz, Marc Pritzker & Thenappan Thenappan. (2017) Chronic use of PAH‐specific therapy in World Health Organization Group III Pulmonary Hypertension: a systematic review and meta‐analysis. Pulmonary Circulation 7:1, pages 145-155.
Crossref
Crossref
Isabel Blanco, Lucilla Piccari & Joan Albert Barberà. (2016) Pulmonary vasculature in COPD: The silent component. Respirology 21:6, pages 984-994.
Crossref
Crossref
James R. Klinger. (2016) Group III Pulmonary Hypertension. Cardiology Clinics 34:3, pages 413-433.
Crossref
Crossref
Michael J. Cuttica. (2016) Pulmonary hypertension associated with lung diseases and hypoxemia. Heart Failure Reviews 21:3, pages 299-308.
Crossref
Crossref
Marius M Hoeper, Vallerie V McLaughlin, Abdullah M Al Dalaan, Toru Satoh & Nazzareno Galiè. (2016) Treatment of pulmonary hypertension. The Lancet Respiratory Medicine 4:4, pages 323-336.
Crossref
Crossref
Nazzareno Galiè, Marc Humbert, Jean-Luc Vachiery, Simon Gibbs, Irene Lang, Adam Torbicki, Gérald Simonneau, Andrew Peacock, Anton Vonk Noordegraaf, Maurice Beghetti, Ardeschir Ghofrani, Miguel Angel Gomez Sanchez, Georg Hansmann, Walter Klepetko, Patrizio Lancellotti, Marco Matucci, Theresa McDonagh, Luc A. Pierard, Pedro T. Trindade, Maurizio Zompatori & Marius Hoeper. (2016) 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. European Heart Journal 37:1, pages 67-119.
Crossref
Crossref
Christopher F. Barnett & Teresa De Marco. 2016. Murray and Nadel's Textbook of Respiratory Medicine. Murray and Nadel's Textbook of Respiratory Medicine
1050
1065.e5
.
Edwin J. R. van Beek & Saeed Mirsadraee. 2016. Multidetector-Row CT of the Thorax. Multidetector-Row CT of the Thorax
379
392
.
Nazzareno Galiè, Marc Humbert, Jean-Luc Vachiery, Simon Gibbs, Irene Lang, Adam Torbicki, Gérald Simonneau, Andrew Peacock, Anton Vonk Noordegraaf, Maurice Beghetti, Ardeschir Ghofrani, Miguel Angel Gomez Sanchez, Georg Hansmann, Walter Klepetko, Patrizio Lancellotti, Marco Matucci, Theresa McDonagh, Luc A. Pierard, Pedro T. Trindade, Maurizio Zompatori & Marius Hoeper. (2015) 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. European Respiratory Journal 46:4, pages 903-975.
Crossref
Crossref
Joan Albert Barberà & Isabel Blanco. (2015) Management of Pulmonary Hypertension in Patients with Chronic Lung Disease. Current Hypertension Reports 17:8.
Crossref
Crossref
Michael Seimetz, Nirmal Parajuli, Alexandra Pichl, Mariola Bednorz, Hossein Ardeschir Ghofrani, Ralph Theo Schermuly, Werner Seeger, Friedrich Grimminger & Norbert Weissmann. (2015) Cigarette Smoke-Induced Emphysema and Pulmonary Hypertension Can Be Prevented by Phosphodiesterase 4 and 5 Inhibition in Mice. PLOS ONE 10:6, pages e0129327.
Crossref
Crossref
Alice M. Turner, Lilla Tamasi, Florence Schleich, Mehmet Hoxha, Ildiko Horvath, Renaud Louis & Neil Barnes. (2015) Clinically relevant subgroups in COPD and asthma. European Respiratory Review 24:136, pages 283-298.
Crossref
Crossref
Anne Girard, Stephane Jouneau, Céline Chabanne, Chahéra Khouatra, Morgane Lannes, Julie Traclet, Ségolène Turquier, P. Delaval, J.-F. Cordier & Vincent Cottin. (2015) Severe Pulmonary Hypertension Associated with COPD: Hemodynamic Improvement with Specific Therapy. Respiration 90:3, pages 220-228.
Crossref
Crossref
Robert P. Frantz. 2015. Diagnosis and Management of Pulmonary Hypertension. Diagnosis and Management of Pulmonary Hypertension
93
113
.
Kara Goss & Tim Lahm. 2015. Diagnosis and Management of Pulmonary Hypertension. Diagnosis and Management of Pulmonary Hypertension
67
92
.
Laura Fossati, Séverine Müller-Mottet, Elisabeth Hasler, Rudolf Speich, Konrad E. Bloch, Lars C. Huber & Silvia Ulrich Somaini. (2014) Long-term Effect of Vasodilator Therapy in Pulmonary Hypertension due to COPD: A Retrospective Analysis. Lung 192:6, pages 987-995.
Crossref
Crossref
Ghazwan Butrous. (2014) The role of phosphodiesterase inhibitors in the management of pulmonary vascular diseases. Global Cardiology Science and Practice 2014:3, pages 42.
Crossref
Crossref
Vincent Cottin. (2014) Hypertension pulmonaire au cours des maladies respiratoires chroniques. La Presse Médicale 43:9, pages 945-956.
Crossref
Crossref
Tamera J. Corte, Gregory J. Keir, Konstantinos Dimopoulos, Luke Howard, Paul A. Corris, Lisa Parfitt, Claire Foley, Monica Yanez-Lopez, Daphne Babalis, Philip Marino, Toby M. Maher, Elizabeth A. Renzoni, Lisa Spencer, Charlie A. Elliot, Surinder S. Birring, Katherine O’Reilly, Michael A. Gatzoulis, Athol U. Wells & Stephen J. Wort. (2014) Bosentan in Pulmonary Hypertension Associated with Fibrotic Idiopathic Interstitial Pneumonia. American Journal of Respiratory and Critical Care Medicine 190:2, pages 208-217.
Crossref
Crossref
Serge Adnot & Steven M. Kawut. (2014) Pulmonary Hypertension and Emphysema: Cure Targeting a Common Cause?. American Journal of Respiratory and Critical Care Medicine 189:11, pages 1291-1292.
Crossref
Crossref
Mark A Giembycz & Donald H Maurice. (2014) Cyclic nucleotide-based therapeutics for chronic obstructive pulmonary disease. Current Opinion in Pharmacology 16, pages 89-107.
Crossref
Crossref
John Faul, Danny Schoors, Sofie Brouwers, Benjamin Scott, Andreas Jerrentrup, Joseph Galvin, Sandra Luitjens & Eamon Dolan. (2014) Creation of an iliac arteriovenous shunt lowers blood pressure in chronic obstructive pulmonary disease patients with hypertension. Journal of Vascular Surgery 59:4, pages 1078-1083.
Crossref
Crossref
Guy Brusselle. (2014) Should we pursue pulmonary vasodilation in patients with COPD?. The Lancet Respiratory Medicine 2:4, pages 252-254.
Crossref
Crossref
Andrew R Goudie, Brian J Lipworth, Pippa J Hopkinson, Li Wei & Allan D Struthers. (2014) Tadalafil in patients with chronic obstructive pulmonary disease: a randomised, double-blind, parallel-group, placebo-controlled trial. The Lancet Respiratory Medicine 2:4, pages 293-300.
Crossref
Crossref
Raed A. Dweik, Sharon Rounds, Serpil C. Erzurum, Stephen Archer, Karen Fagan, Paul M. Hassoun, Nicholas S. Hill, Marc Humbert, Steven M. Kawut, Michael Krowka, Evangelos Michelakis, Nicholas W. Morrell, Kurt Stenmark, Rubin M. Tuder & John Newman. (2014) An Official American Thoracic Society Statement: Pulmonary Hypertension Phenotypes. American Journal of Respiratory and Critical Care Medicine 189:3, pages 345-355.
Crossref
Crossref
Bradley A. Maron, Ronald H. Goldstein, Sharon I. Rounds, Shelley Shapiro, Matthew Jankowich, Eric Garshick, Marilyn L. Moy, David Gagnon & Gaurav Choudhary. (2013) Study Design and Rationale for Investigating Phosphodiesterase type 5 Inhibition for the Treatment of Pulmonary Hypertension Due to Chronic Obstructive Lung Disease: The TADA‐PHiLD (TADAlafil for Pulmonary Hypertension Associated with Chronic Obstructive Lung Disease) Trial. Pulmonary Circulation 3:4, pages 889-897.
Crossref
Crossref
Werner Seeger, Yochai Adir, Joan Albert Barberà, Hunter Champion, John Gerard Coghlan, Vincent Cottin, Teresa De Marco, Nazzareno Galiè, Stefano Ghio, Simon Gibbs, Fernando J. Martinez, Marc J. Semigran, Gerald Simonneau, Athol U. Wells & Jean-Luc Vachiéry. (2013) Pulmonary Hypertension in Chronic Lung Diseases. Journal of the American College of Cardiology 62:25, pages D109-D116.
Crossref
Crossref
Adriano R. Tonelli. (2013) Pulmonary hypertension survival effects and treatment options in cystic fibrosis. Current Opinion in Pulmonary Medicine 19:6, pages 652-661.
Crossref
Crossref
Isabel Blanco, Salud Santos, Joaqím Gea, Rosa Güell, Ferran Torres, Elena Gimeno-Santos, Diego A. Rodriguez, Jordi Vilaró, Begona Gómez, Josep Roca & Joan Albert Barberà. (2013) Sildenafil to improve respiratory rehabilitation outcomes in COPD: a controlled trial. European Respiratory Journal 42:4, pages 982-992.
Crossref
Crossref
Sonja D. Bartolome. (2013) Clinical advances in pulmonary arterial hypertension. Current Opinion in Pulmonary Medicine 19:5, pages 430-436.
Crossref
Crossref
Jeremy P. Wrobel, Catriona A. McLean, Bruce R. Thompson, Christopher R. Stuart‐Andrews, Eldho Paul, Gregory I. Snell & Trevor J. Williams. (2013) Pulmonary Arterial Remodeling in Chronic Obstructive Pulmonary Disease is Lobe Dependent. Pulmonary Circulation 3:3, pages 665-674.
Crossref
Crossref
Julio D DuarteRebekah L Hanson & Roberto F Machado. (2013) Pharmacologic treatments for pulmonary hypertension: exploring pharmacogenomics. Future Cardiology 9:3, pages 335-349.
Crossref
Crossref
Jørn Carlsen, Kasper Hasseriis Andersen, Søren Boesgaard, Martin Iversen, Daniel Steinbrüchel & Claus Bøgelund Andersen. (2013) Pulmonary arterial lesions in explanted lungs after transplantation correlate with severity of pulmonary hypertension in chronic obstructive pulmonary disease. The Journal of Heart and Lung Transplantation 32:3, pages 347-354.
Crossref
Crossref
Stan EjioforAlice M. Turner. (2013) Pharmacotherapies for COPD. Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine 7, pages CCRPM.S7211.
Crossref
Crossref
Barbara A. Cockrill & Aaron B. Waxman. 2013. Pharmacotherapy of Pulmonary Hypertension. Pharmacotherapy of Pulmonary Hypertension
229
255
.